Inserm Transfert
Biotechnology Research • 
Paris, Île-de-France, France • 101-200 Employees
Company overview
| Headquarters | Paris Biopark, 7 rue Watt, PARIS, FRANCE 75013, FR |
| Phone number | +33155030100 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Licensing, Knowledge Transfer, Partnerships, R&D, Public Health, Valorisation, Lifescience, European & International Research Projetcs, Techtransfert |
| Founded | 2000 |
| Employees | 101-200 |
| Socials |
Key Contacts at Inserm Transfert
Savita Bernal
Director Acceleration Of Innovation And Entrepreneurship
Catherine Clusel
Director - Collaborative Research Funding
Anne Cochi
Licensing Director
Olivier Bignolais
Business Development Director
Séverine Barth Beaucourt
Director Proof Of Concept
Mireille Caralp
Health Data Business Development Director
Mallory Wolff
Director Business Development, Strategic Partnerships
Inserm Transfert Email Formats
Inserm Transfert uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@inserm-transfert.fr), used 61.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@inserm-transfert.fr | 61.7% |
{first initial}.{last name} | j.doe@inserm-transfert.fr | 38.3% |
About Inserm Transfert
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation. Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases. In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Inserm Transfert revenue & valuation
| Annual revenue | $10,400,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $33,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Inserm Transfert has 59 employees across 9 departments.
Departments
Number of employees
Funding Data
Inserm Transfert has never raised funding before.
Inserm Transfert Tech Stack
Discover the technologies and tools that power Inserm Transfert's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Video players
JavaScript libraries
JavaScript libraries
CDN
Web servers
JavaScript libraries
Programming languages
Security
Blogs
Spain
United States
Switzerland
Poland
Frequently asked questions
4.8
40,000 users
